| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Pilot Study to Evaluate the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor AZD2171 and Chemotherapy in Locally Advanced and Inflammatory Breast Cancer
|
Denduluri, Neelima
|
|
2005
|
6 |
5 |
p. 460-463
4 p.
|
artikel
|
| 2 |
Chemotherapy-Induced Amenorrhea from Adjuvant Breast Cancer Treatment: The Effect of the Addition of Taxanes
|
Davis, Amy L.
|
|
2005
|
6 |
5 |
p. 421-424
4 p.
|
artikel
|
| 3 |
Concepts and Clinical Trials of Dose-Dense Chemotherapy for Breast Cancer
|
Orzano, Jennifer A.
|
|
2005
|
6 |
5 |
p. 402-411
10 p.
|
artikel
|
| 4 |
Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
|
Lê, Monique G.
|
|
2005
|
6 |
5 |
p. 439-445
7 p.
|
artikel
|
| 5 |
Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial
|
Pelegrí, Amadeu
|
|
2005
|
6 |
5 |
p. 433-438
6 p.
|
artikel
|
| 6 |
2005 Highlights From: ECCO 13—The European Cancer Conference, Paris, France October 30 to November 3, 2005
|
Reddy, G. Kesava
|
|
2005
|
6 |
5 |
p. 380-384
5 p.
|
artikel
|
| 7 |
Reducing the Global Breast Cancer Burden: The Importance of Patterns of Care Research
|
Albain, Kathy S.
|
|
2005
|
6 |
5 |
p. 412-420
9 p.
|
artikel
|
| 8 |
Statins: Health-Promoting Agents Show Promise for Breast Cancer Prevention
|
Kumar, Anjali S.
|
|
2005
|
6 |
5 |
p. 455-459
5 p.
|
artikel
|
| 9 |
The Global Breast Cancer Burden: Variations in Epidemiology and Survival
|
Hortobagyi, Gabriel N.
|
|
2005
|
6 |
5 |
p. 391-401
11 p.
|
artikel
|
| 10 |
Treatment of Chemotherapy-Induced Anemia in Breast Cancer: Results of a Randomized Controlled Trial of Darbepoetin Alfa 200 μg Every 2 Weeks Versus Epoetin Alfa 40,000 U Weekly
|
Senecal, Frank M.
|
|
2005
|
6 |
5 |
p. 446-454
9 p.
|
artikel
|
| 11 |
Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252
|
Perez, Edith A.
|
|
2005
|
6 |
5 |
p. 425-432
8 p.
|
artikel
|
Tijdschrift beschrijving